Search Results
Dr. Pegram on Margetuximab Plus Chemo in HER2+ Breast Cancer
Margetuximab Plus Chemotherapy in HER2+ Breast Cancer
Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast Cancer
Dr. Pegram on a Phase II Trial of MGAH22 in Breast Cancer
Dr. Blackwell Discusses Margetuximab for HER2+ Breast Cancer
SOPHIA: Margetuximab and chemo versus trastuzumab and chemo in HER2 positive MBC after prior ant...
Margenza (Margetuximab)- treatment of adult patients with metastatic HER2- positive breast cancer
Treating HER2+ mBC: Immunotherapy and TKIs
Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast Cancer
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA trials
SOPHIA Trial in R/R HER2+ mBC
An Overview of a Phase II Study of ONT-380 in HER2-Positive Breast Cancer
